INTRODUCTION
In developing mammals, hematopoiesis initially occurs extraembryonically, most prominently in the yolk sac (Silver and Palis, 1997) , and later arises within the embryo in the aorta-gonad-mesonephros (AGM) region (Godin et al., 1993; Medvinsky et al., 1993) and developing endocardium (Nakano et al., 2013) . Definitive hematopoietic stem cells (HSCs), which are responsible for blood production throughout life, first detectibly emerge in the AGM (Müller et al., 1994) and colonize the fetal liver (FL), ultimately occupying niches in the bone marrow (reviewed in Mikkola and Orkin, 2006) . The specification of blood is closely coordinated with the specification of blood vessels, and genetic evidence supports the notion of a shared ontogeny. For example, murine embryos null for Kdr (also known as Flk1) do not develop blood islands or blood vessels and die between embryonic development days 8.5 and 9.5 (Shalaby et al., 1995) . In chimeric embryos, Kdr null cells are not detected in later sites of hematopoiesis such as the FL or adult bone marrow but are found in other mesodermal tissues like heart, kidney, and muscle (Shalaby et al., 1997) . In fact, endothelial cells and hematopoietic cells can be observed in vitro to arise from the same mesodermal progenitors, called hemangioblasts (Choi et al., 1998) .
Previously, our group has isolated human embryonic stem cells (ESCs) whose pluripotent state is maintained in vitro by exogenous growth factor signaling, particularly fibroblast growth factor (FGF), insulin or insulin-like growth factor, and transforming growth factor (Bendall et al., 2007; Chen et al., 2011; Thomson et al., 1998; Vallier et al., 2005; Wang et al., 2007; Xu et al., 2005) . These ESCs, in contrast to their ephemeral progenitor counterparts in vivo, can be cultured for many generations in the pluripotent state-they are fortuitously ''trapped'' in this state by the exogenous growth factor signaling, which sustains the expression of master transcription factors, including POU5F1, SOX2, and NANOG. These same factors, when ectopically expressed, can induce somatic cells to adopt a pluripotent stem (iPS) state (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007) . Once iPS cells are reprogrammed, the ectopic factors are no longer required, as the endogenous factors can be maintained by the appropriate exogenous growth factor signaling.
A concept that thus emerges from these studies is that a core set of factors is central to both the induction and maintenance of a particular cell state. There are now numerous examples of inducing a desired cell state by the ectopic expression of key factors (reviewed in Pereira et al., 2012) , for example, reprogramming fibroblasts to cells with characteristics of cardiomyocytes or hemogenic endothelium (Ieda et al., 2010; Pereira et al., 2013) . In this study, we did not set out to reprogram cells per se; rather, we set out to determine the feasibility of employing core factors to maintain progenitors in culture. We hypothesized it might be possible to expand progenitor cells-without a priori knowledge of the exact exogenous signaling factors required for their maintenance in vitro-merely by ectopically expressing key genes. We identify six factors,establish and maintain a proliferative state with hemangioblast potential.
RESULTS

Identifying Factors that Maintain Hemangioblast Potential
We screened for factors that might maintain hematopoietic progenitors in culture by examining candidate genes that either had literature support for their role in hematopoiesis (for example, Chambers et al., 2007; Elcheva et al., 2014; Petriv et al., 2010) and/or were expressed in FL HSCs. The screen involved electroporating combinations of transcription factors and miRNAs encoded on doxycycline inducible cassettes into murine ESCs stably via the PiggyBac transposase system (Figures 1A and 1B) . Electroporated cells were differentiated on Matrigel, following a previous established protocol (Chiang and Wong, 2011) , to mesoderm cells, and then doxycycline was added to activate the ectopic genes as the cells were further differentiated toward hemogenic endothelium. Four days after the introduction of doxycycline, rare domed colonies formed with tight, defined edges ( Figure 1C , top image). The colonies, composed of small adherent cells, occurred at a frequency of 1 to 2 of 1,000 ESCs transfected with a combination of eight transcription factors and one miRNA, and did not arise in transfected cell populations in the absence of doxycycline ( Figure 1D , compare first two bars; data not shown). The domed colonies were observed in multiple independent ESC lines ( Figure 1E , first bar). These colonies resembled early blast colonies before they differentiate into both endothelial and hematopoietic cells (Lancrin et al., 2009) , except that they continued to grow without apparent differentiation.
In the presence of doxycycline, the cells in the domed colonies were often expandable; that is, the colonies could be picked under a dissecting microscope, gently dissociated with EDTA, and replated on Matrigel and continue to proliferate. The expanding colonies (cultured 11 to 21 days) tended to lose their domed morphology, forming loose associations of scattered cells ( Figure 1C , bottom image). When doxycycline was withdrawn from the expanded populations of cells in N2B27 medium supplemented with the growth factors BMP4, FGF2, VEGF, and the small molecules SB431542 and Br-cAMP (vasculogenic mixture or Vm, following the naming convention used previously; Chiang and Wong, 2011) , the cells expressed PECAM1 and CDH5, surface markers of endothelial cells, at efficiencies ranging from 21% to 87% ( Figure 1F , compare top and bottom graphs, first column). When released from doxycycline and placed in medium supplemented with stem cell factor (SCF), Wnt agonist CHIR99021, interleukin-3, and FLT3L (referred to collectively as SCIF), factors that favor early hematopoiesis (Ruiz-Herguido et al., 2012; Taoudi et al., 2008) , in a hypoxic (1.5% O 2 ) atmosphere, cells were observed to express the canonical hematopoietic marker CD45 ( Figure 1G , compare top and bottom graphs, first column). The ability of the isolates to generate CD45 + cells was less efficient and even more variable (1% to 23% of the population) than the ability of the same isolates to produce endothelial-like cells, suggesting that the emergence of the blood cells required a more complex configuration of ectopic factors to be present in the isolates.
To determine which of the nine factors might be responsible for these phenotypes, dropout experiments were conducted. Each of these nine factors was removed one at a time from the combination to determine which were required for domed colony formation. The removal of Mycn or Sox17 reduced colony numbers by 4-or 11-fold, respectively ( Figure 1D ). Conversely, Mycn and Sox17 together drove the formation of domed colonies in three independent ES lines with frequencies comparable to cells transfected with all nine factors ( Figure 1E ), although the colony sizes induced by the two factors alone tended to be smaller (data not shown). Next, to determine which factor(s) were required for the production of endothelial or blood cells, additional dropout experiments were performed (Figures 1F and 1G) . In these experiments, Mycn and Sox17 were always present in the factor combination to ensure colony formation. The experiments revealed that the absence of Tal1 significantly reduced the ability of the isolates to express endothelial markers upon the withdrawal of doxycycline ( Figure 1F ). In addition, the absence of Lmo2, Pitx2, Gata2, or Tal1 significantly reduced the ability of the isolates to produce CD45 + cells ( Figure 1G ). These data together indicated that six transcription factors, Gata2, Lmo2, Mycn, Pitx2, Sox17, and Tal1, collectively imposed a program in cells that (1) Figure S1A available online) and then were tested for their ability to differentiate to select cell types once released from the progenitor state by the withdrawal of doxycycline. First, cells were cultured in Vm for 3 days. In contrast to control cells maintained with doxycycline, these cells dually expressed the endothelial markers PECAM1 and CDH5 ( Figure 2A ) and efficiently took up acetylated lowdensity lipoprotein (Ac-LDL) ( Figure 2B ). The cells were furthermore able to form capillary-like tubular networks ( Figure 2C ) with lumen ( Figure S1B ) when embedded within Matrigel. Collectively, these data indicate that eHBs can differentiate into functional endothelial cells.
The eHBs were next cultured in medium supplemented with SCIF in a hypoxic (1.5% O 2 ) atmosphere to induce hematopoiesis. We employed markers previously used to trace the ontogeny of hematopoietic populations in early sites of hematopoiesis, including the yolk sac and AGM region (Nishikawa et al., 1998; Taoudi et al., 2008) and/or used to trace the differentiation of hemangioblasts to hematopoietic cells through an endothelial-like state (hemogenic endothelium) (Lancrin et al., 2009 ). In a timedependent fashion, the eHBs appeared to give rise to blood progeny by transiting through an intermediate state in which the endothelial markers TIE2 or CDH5 were coexpressed with the blood markers CD41 or CD45 ( Figures 2D  and S1C ). The transient CDH5 + cells were able to take up Ac-LDL ( Figure S1D ), which supports the notion of their endothelial-like nature, although their ability to do so was not as efficient as the eHB-derived endothelial cells (compare Figures 2B and S1D ). To confirm that the blood cells indeed arose from these putative hemogenic endothelial intermediates, the differentiating cells were sorted into CDH5 + and CDH5 À populations 2 days into the culture and then cultured for 2 days further. The CDH5 + cells robustly gave rise to CD45 + cells, in contrast to their CDH5 À counterparts ( Figure S1E ). These data indicate that eHBs give rise to blood cells through an endothelial-like intermediate state, in a manner consistent with previously described emerging hematopoietic populations either in vitro or in vivo. The eHBs were next tested for their ability to produce hematopoietic cells of different lineages. When placed in conditions akin to those previously described to promote erythropoiesis (Sturgeon et al., 2012) , the cells gave rise to TER119 + erythrocytes (many of which were also CD71 + ; Figure 2E ) that abundantly expressed embryonic hemoglobin, but quite poorly expressed adult hemoglobin (Figure S1F) . This result indicates that the eHBs preferentially give rise to primitive hematopoiesis. When differentiated Figure S1 and Table S1 .
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An Expandable, Inducible Hemangioblast State in conditions similar to those previously employed to generate macrophages (Choi et al., 2011) , the eHBs produced CD45 + /CD11B + (Mac-1) macrophages (Figures 2F and S1G) . When differentiated in Stemline II medium (Sigma) supplemented with SCIF and the megakaryocyte cytokine TPO, the cells gave rise to megakaryocytes and proplatelets, as indicated by the dual expression of the markers CD42D (Takada et al., 1995) and CD41 ( Figure 2G ) and the presence of multinucleated cells ( Figure S1H ). Finally, when differentiated in medium supplemented with SCIF, the eHBs also produced, albeit quite inefficiently, BFU-Es (erythrocyte progenitors), CFU-G/M/GMs (granulocyte and/or macrophage progenitors), and CFU-GEMMs (granulocyte, erythrocyte, macrophage, and megakaryocyte progenitors) ( Figure S1I ). Together, these data indicate the eHBs, when released from control of the ectopic factors, are capable of undergoing multilineage hematopoiesis. Next, the eHBs were assayed for their potential to give rise to smooth muscle cells, a capacity also attributed to hemangioblasts (Yamashita et al., 2000) . After 3 days, differentiation on collagen IV in conditions previously shown to promote the differentiation of smooth muscle cells (Xiao et al., 2007) , the eHBs gave rise to progeny (Figure S1J ) that expressed smooth muscle actin (ACTA2) and the additional smooth muscle markers Cnn1 (calponin 1), Myh11 (smMHC), and Tagln (Sm22a) (reviewed in Owens, 1995) (Figures 2H and S1K ). These data indicate that besides blood and endothelial potential, the eHBs also possess smooth muscle potential.
Finally, we challenged the eHBs to give rise to cells not considered to be the progeny of hemangioblasts. The cells were tested for their ability to produce cardiomyocytes, which arise from progenitors that are related to hemangioblasts, but distinguishable from them (Kattman et al., 2006 (Kattman et al., , 2011 . Aggregates of eHBs and their parent ESC lines were differentiated in conditions based on previous studies (Sargent et al., 2009; Zhang et al., 2012) designed to promote cardiomyocyte differentiation. In contrast to the ESC lines, spontaneously beating cardiomyocytes did not arise detectibly from the eHBs (Figures S1L and S1M) . Instead, at least some of their surviving progeny appear to differentiate into smooth muscle cells under these conditions ( Figure S1M ). Taken together, these data suggest that when released from the ectopic factors, the eHBs preferentially give rise to blood and vascular lineages, evidence that supports their putative hemangioblast identity.
To determine how long in culture the six ectopic factors could maintain the eHB state, two eHB lines were passaged heavily-approximately 117 population doublings, an expansion of over 10 35 from the founding cells-and then differentiated into endothelial, blood, or smooth muscle cells ( Figure S1N ). Even after this extensive passaging, both cell lines were still competent to produce the three cell types, but tended to do so with a reduced efficiency, an effect associated in one line with the silencing of ectopic Gata2 ( Figure S1A ). Figures 3A and 3B ). Three independent eHB lines expressing the six factors ectopically ( Figure S2A ) derived from MEF or FL cells were established from single colonies and assayed for their ability to give rise to endothelial ( Figures 3C, 3D , S2B, and S2C), blood ( Figures 3E, 3F , S2D, and S2E), and smooth muscle ( Figures 3G and S2F ) cells in the absence of doxycycline. The FL-eHBs were able to produce all three cell types. However, the MEF-eHBs tended to perform more poorly, particularly in the production of blood or smooth muscle cells, indicating that the factors do not fully reprogram MEFs, at least in the lines examined. The eHBs derived from cultured cells (ESCs or MEFs) were often found with missegregations of the Y chromosome, possessing XYY, XO, or both (Table S1 ). This result parallels the previously known instability of the Y chromosome in cultured murine ESCs (Eggan et al., 2002) , except that here we detect cells not only containing XO, but also the counterpart XYY. However, all eHBs derived from uncultured FL cells tested so far possess a normal karyotype. These data indicate that primary cells (or perhaps female cells) may be the best sources from which to derive the eHBs. Figure 1A . The eHB-derived cells analyzed included the hematopoietic populations CDH5 + /CD45 À and CDH5 + /CD45 + (differentiated 2 or 3 days, respectively, as described in Figure 2D ) and endothelial cells (differentiated 3 days as described in Figure 2A ). When the transcriptomes of these populations were compared by principal component analysis (Figure 4A ) or unsupervised hierarchical clustering ( Figure 4B ), a clear tendency was revealed. The eHBs grouped near ESCderived KDR + mesoderm cells and away from ESCs. The endothelial progeny of the eHBs grouped with the primary endothelial cells; the blood progeny of the eHBs grouped with FL HSCs. These data suggested the eHBs are trapped at or downstream of mesoderm development. The examination of key marker genes further pinpointed the developmental state of the eHBs. In agreement with Figure S2 for additional data including example FACS dot plots, histograms, and images of hematopoietic colonies and Table S1 .
RNA-Seq Analysis of eHBs and Their Derivatives
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An Expandable, Inducible Hemangioblast State RNA-seq analysis was performed on ESCs and their derivatives, on eHBs and their derivatives, on primary E14.5 FL HSCs, and on primary E11.5 endothelial cells (ECs). Five eHB lines were employed, two derived from ESCs, two derived from FL cells, and one derived from MEFs. See also Figure S3 and Table S1 . the clustering, canonical ESC genes like Pou5f1 (Oct4) and Sox2 are not expressed in the eHBs, and Nanog is poorly detected ( Figure 4C) . The eHBs express a number of genes associated with mesoderm ( Figure S3A ), but do not express the transiently expressed mesoderm regulator T (Brachyury) or Etv2 (Er71) (Figure 4D ), a mesoderm factor expressed concomitantly with T that is required for the formation of the endothelial and hematopoietic lineages, in part by upregulating Kdr (Flk1) (Lee et al., 2008) . Kdr is inefficiently expressed in eHBs ( Figure 4D) , and the several lines tested by fluorescence-activated cell sorting (FACS) do not robustly stain for this marker (data not shown). The downregulation of Kdr is likely due to the ectopic expression of Sox17, as has been previously observed (Nakajima-Takagi et al., 2013) . This notion is supported by the observation that Kdr expression increases in the endothelial or hemogenic endothelial (CDH5 + /CD45 À ) progeny of the eHBs, as the ectopic expression of Sox17 diminishes ( Figures 4D  and S3B ). These data indicate that eHBs are developmentally trapped downstream of T and Etv2 expression and thus do not resemble early, canonical blast colony-forming cells (BL-CFCs) (Choi et al., 1998; Faloon et al., 2000; Fehling et al., 2003; Huber et al., 2004) . The blood or endothelial derivatives of eHBs express a number of hematopoietic and endothelial markers ( Figures  4E, 4F , S3B, and S3C). However, while the emerging blood cells generated from the eHBs express Erg, they fail to express Hoxa9 and Rora ( Figure S3C ). Collectively, these three factors have been previously shown to expand human blood progenitors with high CFU potential (Doulatov et al., 2013) . The absence of Hoxa9 and Rora provides a possible explanation for why the eHBs generate CFUs poorly ( Figures 3F and S1I) . The blood derivatives of the eHBs poorly express the definitive hematopoietic progenitor markers Kit, Ly6a (Sca1), or Procr (Epcr) ( Figures  4E and 4F) , an additional indication that the eHBs preferentially give rise to primitive hematopoiesis. The endothelial progeny of the eHBs better express these three markers, suggesting they may possess hemogenic potential, although this has not been observed. The endothelial progeny of the eHBs do not efficiently express the endothelial marker VWF ( Figure 4F) ; however, this marker has variable expression across the developing murine vasculature (Coffin et al., 1991) . The CDH5 + /CD45 À progeny of the eHBs upregulate a number of endothelial genes whose expression then tends to diminish as the cells acquire CD45 expression ( Figures 4D and 4F) , further supporting the transiently endothelial-like nature of these cells.
A Central Role for FGF
Because eHBs are trapped in a progenitor state, they afford the unique opportunity to examine growth factor signaling on a hemangioblast state prior to its commitment to a particular fate. The ESC-derived eHBs were originally found and maintained with doxycycline in Vm (N2B27 medium supplemented with the growth factors BMP4, FGF2, VEGF, and the small molecules SB431542 and Br-cAMP). In these conditions, the cells associate loosely, migrate as single cells or small groups (''scatter''), and at higher densities form flatter colonies with occasional domed colonies ( Figure 5A ; Movie S1). The morphology of the cells changes as they move: the cells elongate, contract, and often exhibit pronounced lamellipodia. In Vm with doxycycline, the cell populations double on average every 16 hr ( Figure 5B ). In N2B27 medium containing doxycycline without any additional growth factors, the doubling slowed to an average of every 37 hr, and the cells converted to growth in domed colonies, reminiscent of how they often emerge prior to passaging (''No GFs'' Figures 5A and 5B; Movie S2). These observations indicated that one or more of the exogenous factors present in Vm were responsible for stimulating the eHBs to change their growth and morphological characteristics. To determine which factor(s) might be responsible, eHBs were maintained with doxycycline in N2B27 medium supplemented with single additional growth factors. In contrast to the addition of BMP4, the addition of FGF2 alone was sufficient to cause the cells to expand more efficiently, to scatter, and to form flatter colonies (Figures 5A and 5B ; Movie S3). The ability of FGF2 to exert these effects was not appreciably altered by the additional presence of BMP4 ( Figures 5A and 5B) . To determine the means by which FGF2 was altering the growth and morphological characteristics of the eHBs, small molecule inhibitors were employed. For these assays, each inhibitor was titrated on the cells growing in N2B27 medium containing doxycycline and FGF2. In a dosedependent manner, PD173074, a high-affinity inhibitor of the FGF receptor, phenocopied the absence of FGF2 ( Figures 5C and 5D ), indicating that FGF2 signals through its canonical receptors. The FGF receptors target multiple signaling pathways, including the MAPK/ERK or PI3K pathways (reviewed in Eswarakumar et al., 2005) . Indeed, the MEK (ERK kinase) inhibitors PD0325901 and U0126, or the PI3K inhibitor PI828, all revealed a dose-dependent inhibition on the expansion of the eHBs ( Figure 5C ). However, each of these three inhibitors alone could not fully mimic the morphological changes that occur in the absence of FGF2 ( Figure 5D ). Instead, the dual inhibition of the MEK and PI3K pathways better imitated the loss of FGF2 (less so with U0126, markedly with the higher affinity MEK inhibitor PD0325901) in the eHB line RB3.6.5. Furthermore, the PI3K activator 740 Y-P alone failed to promote the expansion of the eHBs in the absence of FGF2 (Figure 5E ), supporting the notion that FGF2 exerts its effects on the eHBs through both MEK and PI3K signaling.
It is not yet clear whether FGF2 activates additional
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An Expandable, Inducible Hemangioblast State (legend continued on next page) signaling pathways in the eHBs, for example, the protein kinase C pathway (Eswarakumar et al., 2005) . We wondered if, besides altering the proliferation and morphology of the eHBs, FGF2 might also be altering their fate decisions. Therefore, four independent eHB cell lines were tested for their ability to produce endothelial cells ( Figures 5F and 5G) , leukocytes (scored broadly as CD45 + cells; Figure 5H ), and erythrocytes ( Figures 5I and 5J ) after being maintained in the absence or presence of FGF2. Cells maintained only in N2B27 medium with doxycycline tended to produce endothelial cells or leukocytes poorly. In contrast, cells additionally supplemented with FGF2 were better able to generate these cell types. This trend did not hold for the production of erythrocytes ( Figures  5I and 5J ). FGF2 did not consistently improve the efficiency by which the eHBs produced these cells; in fact, in some lines, the absence of FGF correlated with improved erythropoiesis (and improved viability of the differentiated cells, data not shown), a finding consistent with previous observations (Weng and Sheng, 2014) . Taken together, these data indicate that FGF2 signaling is a key influence on the eHBs, promoting their expansion, altering their morphology, and poising them for vasculogenesis and leukopoiesis but not erythropoiesis.
DISCUSSION
We have uncovered a set of six transcription factors, Gata2, Lmo2, Mycn, Pitx2, Sox17, and Tal1, that collectively maintain cells in culture with the ability to give rise to blood, endothelial, or smooth muscle progeny. In the continued presence of the transcription factor(s), the progenitor populations expand over many generations and commit to a differentiation program as the ectopic factor(s) are downregulated by the withdrawal of doxycycline. We hypothesize the ability of the eHBs to remain in a proliferative progenitor state is a result of the enduring expression of Mycn and Sox17 because these two factors are central for colony formation. The loss of Sox17 disrupts hematopoiesis in the yolk sac and, more profoundly, within the embryo (Kim et al., 2007) . Recently, the transient, enforced expression of Sox17 has been found to expand a hemogenic endothelial population that gives rise to multilineage hematopoietic cells (Clarke et al., 2013; Nakajima-Takagi et al., 2013) . This activity is thought to occur through the Notch signaling pathway. Notch signaling also regulates Myc in murine hematopoietic progenitors (Satoh et al., 2004) , but to our knowledge, it is unknown whether it likewise regulates Mycn. However, given the parallel functions of Myc and Mycn (Malynn et al., 2000) , these data suggest the hemangioblast state might in part be maintained by persistent Notch signaling. Both Mycn and Sox17 are employed repeatedly during development, and it is thus no surprise that they apparently are not enough, on their own, to maintain a hemangioblast state. This task, we hypothesize, is aided by the other four factors. Indeed, Gata2, Lmo2, or Tal1 null embryos all die early in development with extreme hematopoietic deficiencies (E) Growth in N2B27 medium containing doxycycline, with or without the PI3K activator 740 Y-P (Tocris). (F-I) FACS analysis of the differentiated progeny from four independent eHB lines (each line tested at least once, for replicates the average is shown) maintained in N2B27 medium containing doxycycline, with or without FGF2. Differentiated and scored as exemplified in Figures 1 or 2 Results are from eHB cell lines maintained with doxycycline in N2B27 medium (''No GFs'') or in N2B27 medium supplemented with FGF2, BMP4, both FGF2 and BMP4, or Vm. (B, C, and E) Box sizes represent the minimum to maximum number of cumulative population doublings measured at the indicated times in four to five independent eHB lines (each tested at least once); the line inside the boxes represents the mean. Two ESC-derived eHBs and two or three FL-derived eHBs were employed. See also Table S1 and Movies S1, S2, and S3. (Plotnikov et al., 1999) appears to foster signaling in the eHBs through at least the MEK and PI3K signaling pathways. Perhaps collectively, these pathways (1) alter the morphology and migration of the eHBs, (2) cause the eHBs to expand efficiently, and (3) prime the eHBs to generate endothelial cells and leukocytes. The small molecule inhibitors employed in this study and their targets are depicted.
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An Expandable, Inducible Hemangioblast State (Shivdasani et al., 1995; Tsai et al., 1994; Warren et al., 1994) . Ectopic Lmo2, in concert with Mycn, Hlf, Meis1, Pbx1, Prdm5, Runx1t1, and Zfp37, has recently been shown to reprogram blood cells to definitive HSCs (Riddell et al., 2014) . Ectopic Gata2, Tal1, and Etv2 promote the development of murine hemangioblasts, although it is not clear whether this combination of factors can sustain the expansion of the cells, or induce them from sources other than ESCs .The expression of Pitx2 is specific to HSCs when compared with differentiated blood cells (Degar et al., 2001) , and Pitx2 null embryos die early with a number of developmental defects (Lin et al., 1999; Lu et al., 1999) . However, Pitx2 null HSCs do arise and give rise to differentiated blood progeny (Zhang et al., 2006) , likely indicating some functional redundancy for this factor's participation in hematopoiesis in vivo.
We exploited the fact that the eHBs were trapped as progenitors to analyze the effect of specific growth factors upon them and uncovered a central role for FGF ( Figure 6 ). These data are consistent with studies in which FGF promoted the expansion of BL-CFCs derived from human or murine ESCs (Faloon et al., 2000; Vodyanik et al., 2010) and high proliferative potential hemangioblasts from the murine AGM (Yao et al., 2007) . The eHBs provide a tractable means to study in fine detail the function of FGF or any other growth factors on the development of the blood and blood vessel lineages.
Our study parallels the work of other groups who have demonstrated the capacity of ectopic factors to expand progenitors in vitro; for example, HOXB4 or Myc have been used to briefly propagate murine hematopoietic progenitors (Satoh et al., 2004; Sauvageau et al., 1995) . More recent examples include employing BCL-XL, BMI1, and MYC to expand human megakaryocyte progenitors (Nakamura et al., 2014) ; Myc, Sox2, and an shRNA targeting p53 to expand human erythroid progenitors (Huang et al., 2014) ; and ERG, HOXA9, MYB, RORA, and SOX4 to expand human hematopoietic progenitors with multilineage potential that can transiently give rise to erythroid or myeloid cells in vivo (Doulatov et al., 2013) . The ability to efficiently expand progenitors has broad implications; by identifying the ''resident'' proto-oncogenes in a given progenitor cell and then controlling them ectopically, it may be possible to trap, expand, and study many other types of progenitor cells and their differentiated progeny, particularly those that are not currently able to be maintained in culture.
EXPERIMENTAL PROCEDURES
Mice Strains
The following strains of mice were employed: B6.SJL-Ptprc 
DNA Vectors
The cDNAs for rat Gata2 and murine Lmo2, Tal1, Sox17, Mycn, Pitx2, Hoxb5, and Rbp1 were obtained from Open Biosystems or GeneCopoeia encoded on Gateway Entry vectors or subsequently cloned into them. The sequence encoding miR-130a was amplified by PCR from murine genomic DNA and cloned into a Gateway Entry vector. All cDNAs on Entry vectors were then cloned, using Gateway LR clonase (Life Technologies), into a doxycyclineinducible expression cassette akin to a previously reported construction (Agha-Mohammadi et al., 2004) flanked by PiggyBac terminal repeats on a Gateway Destination vector. All vectors and their sequences are available upon request.
Isolation, Culture, and Cryopreservation of eHBs
Colonies were picked under a dissecting microscope 5 to 8 days (depending on the starting cell type) after induction with 2 mg/ml doxycycline and dissociated by incubation in HEH (0.5 mM EDTA [Fisher] in 1 3 Hank's balanced salt solution supplemented with 10 mM HEPES [both from Life Technologies]) for 5 to 10 min followed by trituration. Cells were pelleted and plated on Matrigel-coated plasticware in medium containing doxycycline. For each passage, typically every 2 days, cells were dissociated with HEH and replated, unless otherwise noted. Karyotype analyses were conducted at the WiCell Research Institute. To efficiently cryopreserve the eHBs, cells were resuspended in N2B27 medium and aliquoted to cyrotubes containing an equal volume of N2B27 medium with 10% DMSO (Sigma), for a final concentration of 5% DMSO, and gently inverted repeatedly to mix. The tubes were frozen in Nalgene ''Mr. Frosty'' freezing containers at À80 C and then placed in liquid nitrogen. Upon thawing rapidly in a 37 C water bath, cells were removed from tubes using large orifice tips, diluted into N2B27 medium, and pelleted to remove DMSO. All cell lines were cultured at 37 C and 5% CO 2 in humidified incubators.
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